The core competitiveness of characteristic API enterprises
The CDMO needs to highlight the technical and compliance of the enterprise, specifically including the scientific research capacity, the abundance of technical drugs (pipeline), and the ability to comply with relevant quality control guidelines and government environmental requirements over time.
 

1.Characteristic API original business, variety competition pattern, production capacity and technical capability are crucial
 

2.Transformation of API - formulation integration, partners and formulation pipeline is crucial, related verification qualification, quality assurance and supervision and management
 

3.First-rate communication, collaboration opportunities and frequent adjustments and access to key project partners to help make knowledge transfer smoother.
 

Puriman is a global leader in pharmaceutical research and development services, providing clinical research and pharmaceutical development services, recognized by many pharmaceutical and biotechnology companies, and now has a complete product line.
 

With more than 20 years of experience in pharmaceutical research and development, we have a team of the world's top professionals covering clinical trials, pharmaceutical development, data management, statistical analysis and other fields. With extensive industry experience and expertise, they are able to provide high quality, customized services to meet the needs of their customers.
 

Puriman is a global leader in pharmaceutical research and development services, providing clinical research and pharmaceutical development services, recognized by many pharmaceutical and biotechnology companies, and now has a complete product line. Puriman is a professional manufacturer of cardiovascular and cerebrovascular, anti-tumor, emergency and rescue drugs, new antibiotics, anticholinergic apis, pharmaceutical intermediates, and has also obtained the national GMP certification enterprise.
 

Puriman invests a lot of money to develop and procure the latest technology and equipment to improve production efficiency and quality. They have the world's leading technology platforms and facilities, including production sites, laboratories and data centers, to provide customers with a full range of technical and facility support.
 

The solid preparation workshop is built in strict accordance with high GMP standards. The production equipment is purchased from the domestic first-class pharmaceutical equipment manufacturers, with a high degree of automation and intelligence. The workshop passed GMP compliance inspection in February 2021, with an annual output of 1 billion tablets and 800 million capsules.
 

BFS Workshop 1 adopts the pharmaceutical industry's advanced blow, filling and sealing integration technology, integrates several manufacturing processes in the same equipment, and completes the entire blow molding, filling and sealing process of plastic containers in a single process in a sterile state, which can effectively ensure product safety. It is mainly used for trial production of new products of small volume injection and CDMO business.
 

BFS Workshop 2 is mainly used for the trial production of single dose eye drops and inhalation solutions and CDMO business
 

Glass ampoule small capacity injection workshop, is mainly used for transfer varieties landing production and new product pilot test.
 

In 2022, in order to create a closed-loop industrial chain and form a "microcycle" of enterprise development ecology, the company set out to establish Henan Fei Ji Tang Pharmaceutical Chain Company Limited, open the online and offline linkage operation mode, and lay out the pharmaceutical e-commerce and retail industry.
 

We will rely on the strong research and development capabilities of Henan Puri Pharmaceutical Technology Co., Ltd. and strive to reserve more than 20 new products a year, taking high-end generic drugs, urgent raw materials and preparations as the leading direction. At the same time, we actively use the national industry policy and MAH system to transfer more than 60 drug numbers from external enterprises to ensure the efficient operation of the new workshop of Puruiman Pharmaceutical and promote the release of enterprise production capacity.
 

Puriman has a rigorous quality assurance system that meets the requirements of major regulatory bodies around the world. Their quality management system follows international quality management standards, including ISO, GMP, etc., to ensure product quality and safety. Puriman employees also undergo rigorous quality management training to ensure that their work meets the highest standards.
 

Adhering to the management philosophy of "quality first, people-oriented" and the enterprise spirit of "advancing with The Times and forging ahead", we continue to forge ahead in the field of medicine. On the basis of the existing workshop, it is planned to build two more anti-tumor injection and freeze-drying production lines to further improve the industrial layout and consolidate the development foundation.
 

Puriman Pharmaceutical Group sincerely invites outstanding enterprises and people of insight at home and abroad to cooperate, share win-win situation, and join hands to create a better future.